SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Kannaway, LLC is active in the industry of natural CBD hemp botanical products and is a subsidiary firm of Medical Marijuana Inc (OTCMKTS:MJNA). The firm announced that it attained a significant jump of 42% in new sales revenue. It was achieved from December 1 through February 28.

During this period, the company confirmed that it is bought by the world’s first publicly listed cannabis firm, Medical Marijuana Inc (OTCMKTS:MJNA). The announcement of the acquisition resulted in a boost in consumer confidence during the same period when the newly acquired firm experienced enormous revenue growth. In the reported period, Kannaway Brand Ambassadors count jumped by an astounding 64%.

The privilege

Apart from the strong sales, TAMM said that it nominated Medical Marijuana’s new subsidiary for their new Start-Up firm of the 2014 honor. Kannaway’s legal advisor, Kevin Thomson who recently was recognized by distributor magazine and directsellinglive.com was also nominated by “TAMM” for Advocate of the Year2014.

Jeff Rogers, the CEO of Kannaway stated that it is a privilege to be acknowledged by TAMM as one of the best new start up firm in the industry. The company is on a mission to educate customers on the facts of hemp history. The inclusion in prestigious category is a reflection of the passion of Medical Marijuana’s and its affiliates towards the mission. The company shares the message of the hemp revitalization in every city across the nation. Kannaway is honored to be a part in repositioning hemp consumer products in the industry across the world.

The scope

Medical Marijuana newly appointed CEO, Stuart Titus addressed the “Kannaway Nation” talking about his professional background and dream for growing the industrial hemp industry. It has to be done through Medical Marijuana’s portfolio firms including Kannaway. He has a track record of generating enormous funds to private and public entities across the nation. In last trading session, the stock price of MJNA declined 3.21% to close at $0.0905.